NORTH AMERICA AND EUROPE ARTIFICIAL PANCREAS MARKET ANALYSIS
North America And Europe Artificial Pancreas Market- Key Developments
In April 2022, Beta Bionics, a medical technology company dedicated to the design, development, and commercialization of the iLet Bionic Pancreas, presented positive results from the multi-center randomized Insulin-Only Bionic Pancreas Pivotal Trial (IO BPPT) at the International Conference on Advanced Technologies and Treatments for Diabetes (ATTD).
In January 2020, Bigfoot Biomedical, Inc., a medical technology start-up, raised US$ 45 million in the initial tranche of a Series C equity financing to support the development and approval of Bigfoot Unity Diabetes Management Program, an injection-based digitized insulin dosing platform that integrates Abbott’s FreeStyle Libre glucose sensing technology.
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India : 
